Gerard Marek

Gerard Marek is the Chief Medical Officer (CMO) with over 25 years of experience in early clinical development and discovery. He served as an Assistant Professor of Psychiatry at Yale University School of Medicine, where he contributed to academic research and education. Marek held the position of Associate Director at Pfizer, where he was involved in significant pharmaceutical developments. At Eli Lilly and Company, he was the Psychiatric Disorders Discovery Biology Chief Scientific Officer (CSO), focusing on psychiatric disorder research. Additionally, he served as the Global Medical Lead at Astellas Pharma, overseeing global medical strategies and initiatives.